// App-Quantinova.ai

: Efficacy and Safety of Cangrelor in Patients Undergoing PCI After Cardio-Pulmonary Resuscitation and/or Cardiogenic Shock. Results of the CAN-SHOCK Registry

Researchers

Presenter

  • Uwe Zeymer

Principal Investigators

  • Tobias Geisler

Medical Centers

  • Institut f. Herzinfarktforschung Ludwigshafen, Ludwigshafen, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

Disease

  • Myocardial infarction

  • Cardiogenic shock

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • cangrelor

Outcome

  • N/A

Study Design

  • Multicenteric

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved